Bio-Matrix Scientific Group, Inc. - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - April 26, 2012



Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R8.htm
EXCEL - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Bio-Matrix Scientific Group, Inc.R9.htm
EX-32.2 - CERTIFICATION - Bio-Matrix Scientific Group, Inc.bmsn_ex322.htm
EX-32.1 - CERTIFICATION - Bio-Matrix Scientific Group, Inc.bmsn_ex321.htm
EX-31.2 - CERTIFICATION - Bio-Matrix Scientific Group, Inc.bmsn_ex312.htm
EX-31.1 - CERTIFICATION - Bio-Matrix Scientific Group, Inc.bmsn_ex311.htm
EX-10.1 - CONVERTIBLE PROMISSORY NOTE - Bio-Matrix Scientific Group, Inc.bmsn_ex101.htm
10-Q - QUARTERLY REPORT - Bio-Matrix Scientific Group, Inc.bmsn_10qv.htm
v2.4.0.6
Consolidated Balance Sheets (unaudited) (USD $)
Mar. 31, 2012
Sep. 30, 2011
Current Assets    
Cash $ 244 $ 331
Prepaid Expenses 39,925 39,925
Total Current Assets 40,169 40,256
Property and Equipment (net of accumulated depreciation) 20,789 20,789
Other Assets    
Deposits 4,200 4,200
Investment in Subsidiary 41,336,361 41,735,443
Total Assets 41,401,519 41,739,643
Current Liabilities    
Accounts Payable 130,507 130,507
Notes Payable 189,732 169,575
Accrued Payroll 777,000 627,000
Accrued Payroll Taxes 23,780 23,780
Accrued Interest 203,869 154,930
Accrued Expenses 5,000 5,000
Convertible Note Payable Net of Unamortized Discount 372,694 313,701
Due to Affiliate 59,740 59,500
Current portion, note payable to affiliated party 1,000 1,000
Total Current Liabilities 1,763,322 1,484,993
Stockholders' Equity    
Preferred Stock ($.0001 par value) 20,000,000 shares authorized; 1,963,821 issued and outstanding as of September 30, 2011 and March 31, 2012 197 197
Series B Preferred Shares ($.0001 par value) 2,000,000 shares authorized; 725,409 issues and outstanding as of September 30, 2011 and March 31, 2012 73 73
Common Stock ($.0001 par value 500,000,000 shares authorized; 72,189,747 shares issued and outstanding as of September 30, 2011 and March 31, 2012 7,219 7,219
Additional Paid in Capital 11,539,640 11,498,731
Contributed Capital 509,355 509,355
Retained Earnings (Deficit) accumulated during the development stage 28,782,323 29,101,648
Equity in Earnings (Losses) of subsidiary (663,649) (264,567)
Deficit attributable to noncontrolling interest in subsidiary (536,961) (536,961)
Total Stockholders' Equity (Deficit) 39,638,197 40,315,695
Total Liabilities and Shareholders' Equity $ 41,401,519 $ 41,800,688 [1]
[1] The numbers in this column, for the year ended September 30, 2011, are derived from audited financials.

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by Bio-Matrix Scientific Group, Inc. and has no official or unofficial affiliation with Bio-Matrix Scientific Group, Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.